# Deciphering the Correlation between Breast Tumor Samples and Cell Lines by Integrating Copy Number Changes and Gene Expression Profiles

**Authors:** Yi Sun, Qi Liu

PMC · DOI: 10.1155/2015/901303 · BioMed Research International · 2015-07-26

## TL;DR

This study compares breast cancer cell lines with tumor samples to find which cell lines best represent different tumor types.

## Contribution

A computational framework is introduced to identify cell lines that closely resemble specific breast tumor subgroups.

## Key findings

- Some breast cancer cell lines correlate well with tumor groups, while others like MCF7 and MDA-MB-231 do not.
- The study provides a guide for selecting suitable cell line models for personalized cancer research.

## Abstract

Breast cancer is one of the most common cancers with high incident rate and high mortality rate worldwide. Although different breast cancer cell lines were widely used in laboratory investigations, accumulated evidences have indicated that genomic differences exist between cancer cell lines and tissue samples in the past decades. The abundant molecular profiles of cancer cell lines and tumor samples deposited in the Cancer Cell Line Encyclopedia and The Cancer Genome Atlas now allow a systematical comparison of the breast cancer cell lines with breast tumors. We depicted the genomic characteristics of breast primary tumors based on the copy number variation and gene expression profiles and the breast cancer cell lines were compared to different subgroups of breast tumors. We identified that some of the breast cancer cell lines show high correlation with the tumor group that agrees with previous knowledge, while a big part of them do not, including the most used MCF7, MDA-MB-231, and T-47D. We presented a computational framework to identify cell lines that mostly resemble a certain tumor group for the breast tumor study. Our investigation presents a useful guide to bridge the gap between cell lines and tumors and helps to select the most suitable cell line models for personalized cancer studies.

## Linked entities

- **Diseases:** breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** TCAP (titin-cap) [NCBI Gene 8557] {aka CMD1N, CMH25, LGMD2G, LGMDR7, T-cap, TELE}, ITGB8 [NCBI Gene 101087724], MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, PSMD3 (proteasome 26S subunit, non-ATPase 3) [NCBI Gene 5709] {aka P58, RPN3, S3, TSTA2}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, BRCA2 (BRCA2 DNA repair associated) [NCBI Gene 675] {aka BRCC2, BROVCA2, FACD, FAD, FAD1, FANCD}, E2F5 (E2F transcription factor 5) [NCBI Gene 1875] {aka E2F-5}, CCND1 (cyclin D1) [NCBI Gene 595] {aka BCL1, D11S287E, PRAD1, U21B31}, BRCA1 (BRCA1 DNA repair associated) [NCBI Gene 672] {aka BRCAI, BRCC1, BROVCA1, FANCS, IRIS, PNCA4}, COL9A1 [NCBI Gene 101086148], CLEC3B (C-type lectin domain family 3 member B) [NCBI Gene 7123] {aka MCDR4, TN, TNA}, CCNE2 (cyclin E2) [NCBI Gene 9134] {aka CYCE2}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, TTYH1 [NCBI Gene 101095059], MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, RET [NCBI Gene 101101086], TOP2A (DNA topoisomerase II alpha) [NCBI Gene 7153] {aka TOP2, TOP2alpha, TOPIIA, TP2A}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, ITGB6 [NCBI Gene 101094363], AKT3 (AKT serine/threonine kinase 3) [NCBI Gene 10000] {aka MPPH, MPPH2, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, AGO2 (argonaute RISC catalytic component 2) [NCBI Gene 27161] {aka CASC7, EIF2C2, LESKRES, LINC00980, PPD, Q10}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}
- **Diseases:** Cancer (MESH:D009369), TN (MESH:C562719), Breast Tumor (MESH:D001943), pleural effusion (MESH:D010996), ER (MESH:D056828), Ovary Cancer (MESH:D010051), tumor metastases (MESH:D009362), Lung Cancer (MESH:D008175), luminal B (MESH:D006509), obesity (MESH:D009765)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** G4502A
- **Cell lines:** HCC2218 — Homo sapiens (Human), Breast ductal carcinoma, Cancer cell line (CVCL_1263), CAL148 — Homo sapiens (Human), Breast carcinoma, Cancer cell line (CVCL_1106), HS742T — Homo sapiens (Human), Undefined cell line type (CVCL_0888), BT483 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_2319), HCC202 — Homo sapiens (Human), Breast ductal carcinoma, Cancer cell line (CVCL_2062), MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), HS343T — Homo sapiens (Human), Undefined cell line type (CVCL_0726), HCC1143 — Homo sapiens (Human), Breast ductal carcinoma, Cancer cell line (CVCL_1245), ZR751 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0588), EFM19 — Homo sapiens (Human), Breast ductal carcinoma, Cancer cell line (CVCL_0253), HCC1937 — Homo sapiens (Human), Breast ductal carcinoma, Cancer cell line (CVCL_0290), CAMA1 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_1115), HCC70 — Homo sapiens (Human), Breast ductal carcinoma, Cancer cell line (CVCL_1270), T-47D — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0553), BT474 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0179), UACC893 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_1782), HS606T — Homo sapiens (Human), Undefined cell line type (CVCL_0819), MDAMB361 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0620), HCC1569 — Homo sapiens (Human), Breast ductal carcinoma, Cancer cell line (CVCL_1255), MCF7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), MDAMB453 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0418), HCC1599 — Homo sapiens (Human), Breast ductal carcinoma, Cancer cell line (CVCL_1256), HS739T — Homo sapiens (Human), Undefined cell line type (CVCL_0882), BT20 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0178)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4529967/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4529967/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC4529967/full.md

---
Source: https://tomesphere.com/paper/PMC4529967